BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16493494)

  • 1. Endothelial cells express a matrix protein which binds activated factor XII in a zinc-independent manner.
    Schousboe I
    Thromb Haemost; 2006 Feb; 95(2):312-9. PubMed ID: 16493494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I; Nystrøm BT; Hansen GH
    FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells.
    Schousboe I
    Eur J Biochem; 2001 Jul; 268(14):3958-63. PubMed ID: 11453989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
    Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP
    J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
    Fernando LP; Natesan S; Joseph K; Kaplan AP
    Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
    Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
    Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
    Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
    Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XII does not initiate prekallikrein activation on endothelial cells.
    Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
    Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions.
    Shibayama Y; Brunnee T; Kaplan AP; Reddigari S
    Braz J Med Biol Res; 1994 Aug; 27(8):1817-28. PubMed ID: 7749371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XII binding to endothelial cells depends on caveolae.
    Schousboe I; Thomsen P; van Deurs B
    Eur J Biochem; 2004 Jul; 271(14):2998-3005. PubMed ID: 15233796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor.
    Schousboe I
    Eur J Biochem; 2003 Jan; 270(1):111-8. PubMed ID: 12492481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
    Mutch NJ; Waters EK; Morrissey JH
    J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor.
    Shibayama Y; Reddigari SR; Teruya M; Nakamura K; Fukunaga Y; Ienaga K; Nishikawa K; Suehiro S; Kaplan AP
    Biochem Pharmacol; 1998 Apr; 55(8):1175-80. PubMed ID: 9719471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
    Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
    Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
    Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells.
    Joseph K; Ghebrehiwet B; Kaplan AP
    Clin Immunol; 1999 Sep; 92(3):246-55. PubMed ID: 10479529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis.
    LaRusch GA; Mahdi F; Shariat-Madar Z; Adams G; Sitrin RG; Zhang WM; McCrae KR; Schmaier AH
    Blood; 2010 Jun; 115(24):5111-20. PubMed ID: 20228268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
    Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
    Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.